Clinical Supervisor AbodeClinical SupervisorVallejo, CaliforniaThe team will engage, house, and provide wrap-around clinical services to the chronically homeless, vulnerable individuals who have Serious Mental Health Disorders, Substance Use Disorders, and/or Chronic Health Conditions.⯠This position will be responsible for assessing the mental health needs of referred individuals living in the County, in the office and at housing sites, as well as clinical supervision to ASWs and MFTs who are working towards licensure.â¯. Experience, understanding and ability to implement theories of biological, psychological, and social development This includes, but is not limited to, an understanding of human behavior and psychopathology, human diversity, interpersonal relationships and family dynamics, mental disorders, stress, and chemical dependency.
Manager, Clinical Workforce Utilization (Scheduling Manager) HealthFlex Home Health ServicesManager, Clinical Workforce Utilization (Scheduling Manager)Oakland, CAThe Manager serves as the central point of coordination between Talent Acquisition, Clinical Leadership, Care Coordinators, and the Intake team, resolving daily field escalations, diagnosing staffing barriers, and driving process improvements that keep caseloads balanced and productivity targets on track. This is a highly cross-functional, data-informed operational role: part air-traffic-control for daily field issues, part analyst building the reporting infrastructure that makes staffing gaps and trends visible before they become problems.
Director, Global Clinical Physician (Immunology) Bristol Myers SquibbDirector, Global Clinical Physician (Immunology)Brisbane, CA$308,700–$374,075 / yearClinical Development Expertise & Strategy: Clinical Strategy & Protocol Design- Collaborate with the Clinical Development Lead to design and develop clinical plans and protocols, with a strategic focus on drug/asset knowledge, disease area science, and regulatory targets. Medical Monitoring: Team Leadership & Collaboration- Serve as a key contributor to the Study Delivery Team (SDT) and Clinical Development Team (CDT), partnering with Clinical Scientists to provide medical oversight on protocol development, including inclusion/exclusion criteria and safety considerations.
Medical Director, Clinical Research Cardiovascular CytokineticsMedical Director, Clinical Research CardiovascularSouth San Francisco, CaliforniaCytokinetics is a specialty cardiovascular biopharmaceutical company, building on its over 25 years of pioneering scientific innovations in muscle biology, and advancing a pipeline of potential new medicines for patients suffering from diseases of cardiac muscle dysfunction. The individual will also partner with members of the new product planning group to assist with market research, defining the target product profile, and health economics and outcomes research, as well as serving as a consultant to evaluate new projects in research and outside licensing opportunities.
Medical Director, Clinical Research Neuromuscular CytokineticsMedical Director, Clinical Research NeuromuscularSouth San Francisco, CaliforniaMD or MD/PhD degree with internal medicine or neurology board certification by the American Board of Internal Medicine with a minimum of 2+ years of experience in clinical development, either in a biotechnology or pharmaceutical company or as a clinical investigator, including industry-sponsored multi-center trials. Cytokinetics is a specialty cardiovascular biopharmaceutical company, building on its over 25 years of pioneering scientific innovations in muscle biology, and advancing a pipeline of potential new medicines for patients suffering from diseases of cardiac muscle dysfunction.
Associate Director, Clinical Operations Compliance & Training Revolution Medicines, Inc.Associate Director, Clinical Operations Compliance & TrainingRedwood City, CA$186,000–$233,000 / yearThe company's RAS(ON) inhibitors daraxonrasib (RMC-6236), a RAS(ON) multi-selective inhibitor; elironrasib (RMC-6291), a RAS(ON) G12C-selective inhibitor; zoldonrasib (RMC-9805), a RAS(ON) G12D-selective inhibitor; and RMC-5127, a RAS(ON) G12V-selective inhibitor, are currently in clinical development. The company's R&D pipeline comprises RAS(ON) Inhibitors designed to suppress diverse oncogenic variants of RAS proteins, and RAS Companion Inhibitors for use in combination treatment strategies.
Director, Clinical Data Management Revolution Medicines, Inc.Director, Clinical Data ManagementRedwood City, CA$211,000–$264,000 / yearThe company's RAS(ON) inhibitors daraxonrasib (RMC-6236), a RAS(ON) multi-selective inhibitor; elironrasib (RMC-6291), a RAS(ON) G12C-selective inhibitor; zoldonrasib (RMC-9805), a RAS(ON) G12D-selective inhibitor; and RMC-5127, a RAS(ON) G12V-selective inhibitor, are currently in clinical development. Provides CDM oversight of outsourced and partner-resourced clinical trials including scoping trials, project management, relationship management, approval of deliverables, and coordination of internal reviewers.
Associate Director, Clinical Quality Assurance Revolution Medicines, Inc.Associate Director, Clinical Quality AssuranceRedwood City, CA$186,000–$233,000 / yearThe company's RAS(ON) inhibitors daraxonrasib (RMC-6236), a RAS(ON) multi-selective inhibitor; elironrasib (RMC-6291), a RAS(ON) G12C-selective inhibitor; zoldonrasib (RMC-9805), a RAS(ON) G12D-selective inhibitor; and RMC-5127, a RAS(ON) G12V-selective inhibitor, are currently in clinical development. Please note that base pay salary range is one part of the overall total rewards program at RevMed, which includes competitive cash compensation, robust equity awards, strong benefits, and significant learning and development opportunities.
Associate Director, Biostatistics Clinical Late Stage Revolution Medicines, Inc.Associate Director, Biostatistics Clinical Late StageRedwood City, CA$186,000–$233,000 / yearThe company's RAS(ON) inhibitors daraxonrasib (RMC-6236), a RAS(ON) multi-selective inhibitor; elironrasib (RMC-6291), a RAS(ON) G12C-selective inhibitor; zoldonrasib (RMC-9805), a RAS(ON) G12D-selective inhibitor; and RMC-5127, a RAS(ON) G12V-selective inhibitor, are currently in clinical development. Please note that base pay salary range is one part of the overall total rewards program at RevMed, which includes competitive cash compensation, robust equity awards, strong benefits, and significant learning and development opportunities.
Clinical Laboratory Scientist, Oncology (PM Shift) BillionToOneClinical Laboratory Scientist, Oncology (PM Shift)Menlo Park, CA$59.14–$67.29 / hourAt BillionToOne, we've built a category-defining, publicly traded company on Nasdaq where transparency fuels trust, collaboration drives breakthroughs, and every contribution moves the needle on our mission to make life-changing diagnostics accessible to all. Unity Confirm enables non-invasive confirmation for high-risk screening results through the capture of intact circulating fetal cells using BillionToOne’s Fetal Cell Capture Technology.
Clinical Laboratory Scientist, Prenatal BillionToOneClinical Laboratory Scientist, PrenatalUnion City, CA$59.14–$86.97 / hourWe are looking for driven Clinical Laboratory Scientists (with California Clinical Laboratory Scientist License) to perform UNITY, the only non-invasive prenatal test (NIPT) that can detect inherited disorders such as sickle cell disease, spinal muscular atrophy, and cystic fibrosis in the baby directly from maternal blood. At BillionToOne, we've built a category-defining, publicly traded company on Nasdaq where transparency fuels trust, collaboration drives breakthroughs, and every contribution moves the needle on our mission to make life-changing diagnostics accessible to all.
Associate Director, Clinical Data Management Revolution Medicines, Inc.Associate Director, Clinical Data ManagementRedwood City, CA$186,000–$233,000 / yearThe company's RAS(ON) inhibitors daraxonrasib (RMC-6236), a RAS(ON) multi-selective inhibitor; elironrasib (RMC-6291), a RAS(ON) G12C-selective inhibitor; zoldonrasib (RMC-9805), a RAS(ON) G12D-selective inhibitor; and RMC-5127, a RAS(ON) G12V-selective inhibitor, are currently in clinical development. Provides CDM oversight of outsourced and partner-resourced clinical trials including scoping trials, project management, relationship management, approval of deliverables, and coordination of internal reviewers.
Director, Biostatistics, Late Clinical Stage Revolution Medicines, Inc.Director, Biostatistics, Late Clinical StageRedwood City, CA$211,000–$264,000 / yearThe company's RAS(ON) inhibitors daraxonrasib (RMC-6236), a RAS(ON) multi-selective inhibitor; elironrasib (RMC-6291), a RAS(ON) G12C-selective inhibitor; zoldonrasib (RMC-9805), a RAS(ON) G12D-selective inhibitor; and RMC-5127, a RAS(ON) G12V-selective inhibitor, are currently in clinical development. The Opportunity: Playing a critical role as a lead statistician for clinical program(s) and studies in clinical late-stage development and the subject matter expert (SME) in Biostatistics within Quantitative Sciences function, this position is to provide statistical leadership and support for clinical development strategy and clinical studies through product life cycle.
Senior Manager, Analytical AI Clinical Development Bristol Myers SquibbSenior Manager, Analytical AI Clinical DevelopmentBrisbane, CA$167,370–$202,807 / yearAligned with Bristol Myers Squibb's mission to advance clinical development through data-driven innovation, the Senior Manager- Analytical AI in Clinical Development will play a key role in designing and deploying machine learning pipelines to optimize clinical trial operations. Stay Ahead of AI Trends in Clinical Development: Continuously evaluate emerging trends and advancements in data science and AI, integrating cutting-edge techniques such as natural language processing (NLP) and predictive analytics into clinical trial workflows.
Executive Director, Clinical Supply Chain Revolution Medicines, Inc.Executive Director, Clinical Supply ChainRedwood City, CA$265,000–$331,000 / yearThe company's RAS(ON) inhibitors daraxonrasib (RMC-6236), a RAS(ON) multi-selective inhibitor; elironrasib (RMC-6291), a RAS(ON) G12C-selective inhibitor; zoldonrasib (RMC-9805), a RAS(ON) G12D-selective inhibitor; and RMC-5127, a RAS(ON) G12V-selective inhibitor, are currently in clinical development. Please note that base pay salary range is one part of the overall total rewards program at RevMed, which includes competitive cash compensation, robust equity awards, strong benefits, and significant learning and development opportunities.
Associate Director, Clinical Supply Chain Revolution Medicines, Inc.Associate Director, Clinical Supply ChainRedwood City, CA$186,000–$233,000 / yearLead and manage clinical supply and logistics activities, for blinded as well as open label studies, including but not limited to: demand forecasting and supply planning, IRT start-up and maintenance, label generation and approval, packaging and labeling operations, release and distribution, expiry extension, cold chain management, and inventory management. The company's RAS(ON) inhibitors daraxonrasib (RMC-6236), a RAS(ON) multi-selective inhibitor; elironrasib (RMC-6291), a RAS(ON) G12C-selective inhibitor; zoldonrasib (RMC-9805), a RAS(ON) G12D-selective inhibitor; and RMC-5127, a RAS(ON) G12V-selective inhibitor, are currently in clinical development.
RN Clinical Supervisor Institute on AgingRN Clinical SupervisorSan Francisco, CA$123,000–$128,000 / yearMultipurpose Senior Services Program (MSSP) provides interdisciplinary care management services to individuals at risk of being institutionalization or currently institutionalized that can transition home or "home like setting" providing services are in place to help them remain safe in the community. Develops and maintains collaborative working relationships with community individuals, HHA's, PCA's, groups and organizations; takes advantage of opportunities to educate the public about MSSP services.
Clinical Laboratory Scientist Lead, Hematology, Coag and UA Sutter HealthClinical Laboratory Scientist Lead, Hematology, Coag and UAOakland, CaliforniaDemonstrated knowledge and technical competence in routine specimen collection, preparation, testing applications, laboratory operations, and quality assurance in one or more assigned clinical specialty areas; examples: Chemistry, Special Chemistry, Hematology/Coagulation, Urinalysis and Transfusion Service. • Duties routinely include staff scheduling, arranging coverage for staff absences, assigning work, prioritizing work, directing problem-solving and troubleshooting, ensuring shift-to-shift continuity, and managing customer complaints or inquiries.
NewSenior Clinical Manager Easterseals Northern CaliforniaSenior Clinical ManagerBurlingame, CaliforniaLeads and provides direct supervision and mentorship to Clinical Managers and their teams to ensure effective service delivery, balancing clinical and administrative priorities, staff development, and achievement of quality and performance metrics in alignment with our Family of Companies (FoC) Values: Bold : Act courageously and think Differently. Our services provide exceptional, individualized, family-centered services to empower people with intellectual or developmental disabilities to achieve their goals and live independent, fulfilling lives with justice, equity, and inclusion as our guiding values.
Global Development Lead (Gdl), Clinical Development Revolution Medicines, Inc.Global Development Lead (Gdl), Clinical DevelopmentRedwood City, CA$369,000–$424,000 / yearPartner closely with the Project Team Leader (PTL) or Lifecycle Team Leader (LCL) to ensure that clinical development strategy, positions and decision-making are fully represented and integrated within lifecycle planning and decision-making for the molecule, with clear alignment on roles, decision rights and accountability. The company's RAS(ON) inhibitors daraxonrasib (RMC-6236), a RAS(ON) multi-selective inhibitor; elironrasib (RMC-6291), a RAS(ON) G12C-selective inhibitor; zoldonrasib (RMC-9805), a RAS(ON) G12D-selective inhibitor; and RMC-5127, a RAS(ON) G12V-selective inhibitor, are currently in clinical development.